| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0098 | 0.8 |